Capital International Investors 13D/13G Filings for Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

Capital International Investors 13D and 13G filings for Biohaven Pharmaceutical Holding Company Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2022-06-10
08:41 am
Sale
2022-06-10 13G Biohaven Pharmaceutical Holding Company Ltd.
BHVN
Capital International Investors 1,569,985
2.200%
-3,534,516decrease
(-69.24%)
Filing
2022-02-11
11:19 am
Sale
2022-02-14 13G Biohaven Pharmaceutical Holding Company Ltd.
BHVN
Capital International Investors 5,104,501
7.800%
-948,967decrease
(-15.68%)
Filing
2021-02-16
6:04 pm
Purchase
2021-02-16 13G Biohaven Pharmaceutical Holding Company Ltd.
BHVN
Capital International Investors 6,053,468
10.100%
6,053,468increase
(New Position)
Filing